Neurocrine Bioscience buy Cantor Fitzgerald
Start price
10.04.24
/
50%
€129.55
Target price
10.04.25
€144.01
Performance (%)
-1.20%
Price
03.07.24
€128.00
Summary
This prediction is currently active. With a performance of -1.20%, the BUY prediction for Neurocrine Bioscience by Cantor_Fitzgerald is down slightly. This prediction currently runs until 10.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 1.951% | 1.951% |
iShares Core DAX® | 1.133% | -0.156% |
iShares Nasdaq 100 | 0.815% | 8.801% |
iShares Nikkei 225® | 1.990% | 3.286% |
iShares S&P 500 | -0.014% | 5.438% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€102.55
24.10.23
24.10.23
-
24.10.24
24.10.24
23.50%
03.07.24
03.07.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€126.70
13.09.24
13.09.24
19.35%
03.07.24
03.07.24